Express News | JP Morgan Maintains Overweight on Apellis Pharmaceuticals, Lowers Price Target to $64

BenzingaAug 13 08:31 ET

J.P. Morgan Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Announces Target Price $64

Moomoo NewsAug 13 08:31 ET · Ratings

Express News | Apellis Pharmaceuticals Inc : JP Morgan Cuts Target Price to $64 From $72

ReutersAug 12 22:58 ET

Analysts Conflicted on These Healthcare Names: Edgewise Therapeutics (EWTX), Humacyte (HUMA) and Apellis Pharmaceuticals (APLS)

TipRanksAug 12 07:12 ET · Ratings

Express News | Apellis Pharmaceuticals Inc : UBS Cuts Target Price to $83 From $85

ReutersAug 9 10:12 ET

Wedbush Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS)

TipRanksAug 9 09:29 ET · Ratings